Ann: Quarterly Activities Report and Appendix 4C, page-74

I won't bother to list what Nuheara has achieved or developed so far. I think you need to find this out for yourself.

I will say that watching only the financials of a small tech start-up trying to break a new technology into a market that they have to create is likely to provide plenty of opportunities to despair.

However, in response to some other bits ...

NHS: Nuheara clearly stated that the NHS will be revising the part associated with IQbudsBOOST in May. Its only May 1st today.

Specsavers: Specsavers is a separate business to Nuheara. What Specsavers are doing as part of their trial of the Nuheara product/s is not for Nuheara to announce. If you want information on how the trial is progressing, and you are a shareholder, perhaps try ringing Justin Miller and asking him.

Without knowing the details of many different factors, its pretty hard to comment on inventory levels. I'd expect large runs provide cheaper unit cost, so I wouldn't expect inventory to remain stable.

This is a technology company developing new technology. Its good to see they are constantly moving forward. The MAX are the flagship because they are top of the range. They are based on the new form factor of the LiveIQ - and are exceptional in terms of multiple processors on each ear, no occlusion issues, etc etc. But as yet, the MAX is only under development, so its not surprising it is not part of the NHS contract.

As Nuheara are creating the market for their product, its good to see they are learning and adjusting their strategies. Massive amounts of previously non-existent data is now coming to them via the usage of their products by consumers. Based on this data, they have pivoted once away from CE to Hearing Health, have developed a focus on consultative selling processes, have built marketing capacity and styles to suit both the European and US markets, and have developed IQConnect and the IQStore. All sounds good to me.

Have you read how part of the shift has been to increase margins? Sounds like the right thing to do.

No other player has come along. In fact they are falling by the wayside as they find it very difficult to do what Nuheara have. I suggest you read these two articles - you do seem to be very uniformed on this.
https://www.wareable.com/hearables/bragi-hearables-hard-to-build-7134
https://www.wareable.com/hearables/best-hearables-smart-wireless-earbuds
Even the biggest of companies are struggling to match what Nuheara has developed. Apples Airpods 3 are technologically way behind what Nuheara have developed.

I've pretty much just stuck to facts here. The rest of your post is your opinions - which you are entitled to.

Nuheara will need more cash - but until it happens we don't know what form that will be. Certainly the people and funds Justin was invited to speak to in New York recently are not short a $.

And what makes you think $77m is a lot for the technology? Doppler were looking for $550m USD when they simply had a rough pair of HereOnes - no match for the original IQbuds.

Obviously you can find many reasons to put your capital somewhere else, but do be aware that a few of your reasons are misinformed.